-
requirements in Section 64 of the Schleswig-Holstein Higher Education Act (HSG). After successful evaluation of the first phase of the junior professorship, the aim is to extend the temporary civil servant
-
Vagelos College of Physicians and Surgeons. Our research investigates the function of T cells as they pertain to human diseases, specifically autoimmune disease and cancer. We develop and apply a diverse
-
the applicant screening process. If you need assistance in completing this application or during any phase of the interview process, please contact the Office of Human Resources & Institutional Equity by phone at
-
or machine learning. The Postdoctoral Fellow will be responsible for developing in vitro diagnosis technologies and approaches to detect and measure biomarkers associated with important human diseases and to
-
metabolic diseases, including diabetes, obesity and cardiac arrhythmias. Our NIH-funded lab uses a combination of state-of-the-art molecular techniques to complement mouse and human models of disease. Current
-
research in areas from molecules to medicines, and from patient to policy, across a range of therapeutic areas. Our school has a very large portfolio of human anatomy teaching. We teach human anatomy
-
. The successful candidates will have a strong commitment to a career in education and will contribute to excellence in teaching and curriculum development. Lecturer in First Year Biology – Human or Molecular
-
-2020) of the Human Immunopeptidome Project. He has a total citation of >4400 times to date and is the recipient of multiple Awards and Recognitions. Please see https://medicine.yale.edu/profile/etienne
-
probes (e.g. Neuropixels) simultaneously from cortical and subcortical regions of non-human primates, in combination with chemogenetic circuit manipulation and computational modeling. This project is
-
host and pathogen. We focus particularly on the immunometabolic pathways exploited by bacterial pathogens to establish themselves in the human lung. If you are passionate about advancing our